TIMP2 and neoplasm: In analyzing tumor vascularization by immunofluorescence staining for endothelial cell marker PECAM-1, the microvessels of HSA/TIMP-2-treated tumor tissue demonstrated a significant 39.2% decrease in PECAM-1 level compared with the control group (Fig. 3C, D; P<0.01).